Skip to content
  • Debatforum
  • Seneste
  • Populære
  • Bruger
Temaer
  • Light
  • Dark

Kollaps
FORSIDEN
Log ind Opret konto

Genmab — September 2020

Planlagt Fastgjort Låst Flyttet Genmab
1.0k Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • S Offline
    S Offline
    Sukkeralf
    wrote on sidst redigeret af
    #138

    https://endpts.com/dabbling-in-cd47-pfizer-infuses-25m-into-a-biotech-player-touting-positive-monotherapy-data/

    1 Reply Last reply
    0
    • S Offline
      S Offline
      Sukkeralf
      wrote on sidst redigeret af
      #139

      It’s not necessarily that Trillium plans to compete with a single agent; CSO Bob Uger listed anti-PD-(L)1 drugs, proteasome inhibitors, Darzalex, Erbitux and Folotyn as potential pairings for different indications. But having solid monotherapy data as a foundation gives execs more confidence that their drug would do even better in combo.

      1 Reply Last reply
      0
      • S Offline
        S Offline
        Sukkeralf
        wrote on sidst redigeret af
        #140

        Så nu håber man bare snart, at Genmab nærmer sig en IND - formentlig et bispecifikt antistof. Håber den tifældigvis dukker op på tavlen til CMD, hvor der måske åbnes op for forventninger til IND´er i 2021

        1 Reply Last reply
        0
        • G Offline
          G Offline
          GeorgeBest
          wrote on sidst redigeret af
          #141

          Genmab to present at Morgan Stanley event 15.9.20. Webcast will be available https://ir.genmab.com/news-releases/news-release-details/genmab-present-morgan-stanley-18th-annual-global-healthcare

          1 Reply Last reply
          0
          • E Offline
            E Offline
            E_L
            wrote on sidst redigeret af
            #142

            they are also presenting at Citi this week, not sure if we can see anything from that

            1 Reply Last reply
            0
            • E Offline
              E Offline
              E_L
              wrote on sidst redigeret af
              #143

              yes, CD47 is clearly the hot target atm. Genmab better hurry, you 'Blink' and you miss your opportunity 😉

              1 Reply Last reply
              0
              • E Offline
                E Offline
                E_L
                wrote on sidst redigeret af
                #144

                New: Trial of the Safety and Efficacy of Epcoritamab in Japanese Subjects With R/R B-NHL https://clinicaltrials.gov/ct2/show/NCT04542824?term=NCT04542824&draw=2&rank=1

                1 Reply Last reply
                0
                • Helge_LarsenPI-redaktørH Offline
                  Helge_LarsenPI-redaktørH Offline
                  Helge_LarsenPI-redaktør
                  wrote on sidst redigeret af
                  #145

                  Join Genmab at #SOHO2020, a virtual event from September 9 to 12, 2020. Visit our virtual booth at http://genmab-at-soho-2020.com to get the latest information about our presentations, antibody platforms and pipeline. Get more info at http://soho2020.com @SocietyofHemOnc

                  1 Reply Last reply
                  0
                  • E Offline
                    E Offline
                    E_L
                    wrote on sidst redigeret af
                    #146

                    BAML sees Kesimpta in MS $5bn peak sales $5bn

                    1 Reply Last reply
                    0
                    • SolsenS Offline
                      SolsenS Offline
                      Solsen
                      wrote on sidst redigeret af
                      #147

                      I like that 😉

                      1 Reply Last reply
                      0
                      • E Offline
                        E Offline
                        E_L
                        wrote on sidst redigeret af
                        #148

                        If anyone is interested in a position as postdoctoral dara researcher with dr. Niels van Donk

                        • https://www.academictransfer.com/en/294131/postdoc-cancer-center-amsterdam/
                        1 Reply Last reply
                        0
                        • T Offline
                          T Offline
                          transalp
                          wrote on sidst redigeret af
                          #149

                          Go morgen.. 🙂

                          1 Reply Last reply
                          0
                          • M Offline
                            M Offline
                            Mcjean
                            wrote on sidst redigeret af
                            #150

                            Maybe now E L from Genmabchat will join the adventure and use some of his huge energy in this stock, because now Qfuel arrive to netherland:-D

                            1 Reply Last reply
                            0
                            • E Offline
                              E Offline
                              E_L
                              wrote on sidst redigeret af
                              #151

                              E L from Genmabchat thinks he missed that -plastic- boat 😉 But he says that if he can sell his Genmabs at 18.000 he may look into it again 😄

                              1 Reply Last reply
                              0
                              • M Offline
                                M Offline
                                Mcjean
                                wrote on sidst redigeret af
                                #152

                                🙂 Whole new business my friend, you better join

                                1 Reply Last reply
                                0
                                • T Offline
                                  T Offline
                                  Topo
                                  wrote on sidst redigeret af
                                  #153

                                  Jeg skylder sgu dig en øl for dit skriv om qfuel Mcjean 🙂

                                  1 Reply Last reply
                                  0
                                  • StockBullS Offline
                                    StockBullS Offline
                                    StockBull
                                    wrote on sidst redigeret af
                                    #154

                                    https://nbg1.your-objectstorage.com/proinvestor-dev/forum/boards/86671_Oct_8_target.JPG mulig kursudvikling kommende måned såfremt markedet opføre sig pænt

                                    1 Reply Last reply
                                    0
                                    • S Offline
                                      S Offline
                                      Sukkeralf
                                      wrote on sidst redigeret af
                                      #155

                                      Just a moment...

                                      favicon

                                      (www.firstwordpharma.com)

                                      1 Reply Last reply
                                      0
                                      • S Offline
                                        S Offline
                                        Sukkeralf
                                        wrote on sidst redigeret af
                                        #156

                                        test

                                        1 Reply Last reply
                                        0
                                        • S Offline
                                          S Offline
                                          Sukkeralf
                                          wrote on sidst redigeret af
                                          #157

                                          The study found the addition of NINLARO to lenalidomide and dexamethasone resulted in a 13.5 month increase in median progression-free survival (PFS) (35.3 months in the NINLARO arm, compared to 21.8 months in the placebo arm

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind

                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          • First post
                                            Last post
                                          0
                                          • Debatforum
                                          • Seneste
                                          • Populære
                                          • Bruger